As of April 28, 2026, Vaxcyte's top three insider holders are Grant Pickering (Chief Executive Officer, 496.94K shares), Grant Pickering (Chief Executive Officer, 345.66K shares), Jeff Fairman (Vp, Research, 286.23K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Grant Pickering | Chief Executive Officer | 496,939 | 0 | 11 Mar, 2026 |
| Grant Pickering | Chief Executive Officer | 0 | 345,660 | 28 Jun, 2022 |
| Jeff Fairman | Vp, Research | 0 | 286,227 | 28 Oct, 2022 |
| Jim Wassil | Chief Operating Officer | 162,994 | 0 | 03 Apr, 2026 |
| Jim Wassil | Chief Operating Officer | 162,994 | 0 | 03 Apr, 2026 |
| Grant Pickering | Chief Executive Officer | 0 | 136,215 | 10 Dec, 2024 |
| Andrew Guggenhime | President And Cfo | 104,395 | 0 | 11 Mar, 2026 |
| Harpreet S. Dhaliwal | Chief Technical Ops Officer | 75,976 | 0 | 11 Mar, 2026 |
| Andrew Guggenhime | President And Cfo | 0 | 61,850 | 16 Jan, 2026 |
| Mikhail Eydelman | Svp, Gen Counsel Corp Sec | 41,620 | 0 | 07 Mar, 2025 |
| Elvia Cowan | Svp, Finance Cao | 28,975 | 0 | 08 Apr, 2026 |
| Heath Lukatch | - | 17,216 | 0 | 16 Jun, 2025 |
| Jeff Fairman | Vp, Research | 17,143 | 0 | 07 Sep, 2022 |
| Paul Sauer | Svp Process Dev, Manufacturing | 13,822 | 0 | 07 Sep, 2022 |
| Teri Loxam | - | 10,216 | 0 | 16 Jun, 2025 |
| Halley E Gilbert | - | 10,216 | 0 | 16 Jun, 2025 |
| Anne S Drapeau | - | 10,216 | 0 | 16 Jun, 2025 |
| Peter Hirth | - | 7,175 | 0 | 10 Jun, 2024 |
| Carlos V Paya | - | 0 | 5,625 | 09 Dec, 2024 |
| Michael E. Kamarck | - | 5,625 | 0 | 15 Jun, 2023 |
| Carlos V Paya | - | 4,591 | 0 | 16 Jun, 2025 |
| Jacks Lee | - | 4,591 | 0 | 16 Jun, 2025 |
| Jane Wright-Mitchell | General Counsel | 3,125 | 0 | 18 Aug, 2021 |
| Jane Wright-Mitchell | General Counsel | 3,125 | 0 | 18 Aug, 2021 |
| John Furey | - | 3,041 | 0 | 16 Jun, 2025 |
| Olivier Brandicourt | - | 2,505 | 0 | 16 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Apr, 2026 | Elvia Cowan | Common Stock | A | 3,000 | $25.92 | 31,975 | D | M |
| 07 Apr, 2026 | Elvia Cowan | Common Stock | D | 3,000 | $60.00 | 28,975 | D | S |
| 07 Apr, 2026 | Elvia Cowan | Stock Option (right to buy) | D | 3,000 | $0.00 | 93,068 | D | M |
| 01 Apr, 2026 | Jim Wassil | Common Stock | D | 1,412 | $58.14 | 165,406 | D | S |
| 01 Apr, 2026 | Jim Wassil | Common Stock | D | 1,412 | $58.14 | 165,406 | D | S |
| 01 Apr, 2026 | Jim Wassil | Common Stock | D | 838 | $58.93 | 162,994 | D | S |
| 01 Apr, 2026 | Jim Wassil | Common Stock | D | 838 | $58.93 | 162,994 | D | S |
| 17 Mar, 2026 | Elvia Cowan | Common Stock | D | 1,487 | $55.39 | 29,380 | D | S |
| 17 Mar, 2026 | Elvia Cowan | Common Stock | D | 405 | $56.26 | 28,975 | D | S |
| 09 Mar, 2026 | Jim Wassil | Common Stock | D | 975 | $59.32 | 174,213 | D | F |
| 09 Mar, 2026 | Elvia Cowan | Common Stock | D | 495 | $59.32 | 30,867 | D | F |
| 09 Mar, 2026 | Andrew Guggenhime | Common Stock | D | 1,021 | $59.32 | 104,395 | D | F |
| 09 Mar, 2026 | Jim Wassil | Common Stock | D | 975 | $59.32 | 174,213 | D | F |
| 09 Mar, 2026 | Harpreet S. Dhaliwal | Common Stock | D | 604 | $59.32 | 75,976 | D | F |
| 09 Mar, 2026 | Grant Pickering | Common Stock | D | 3,685 | $59.32 | 496,939 | D | F |
| 11 Mar, 2026 | Elvia Cowan | Common Stock | A | 2,500 | $25.92 | 33,367 | D | M |
| 10 Mar, 2026 | Jim Wassil | Common Stock | D | 2,427 | $58.32 | 171,786 | D | S |
| 10 Mar, 2026 | Jim Wassil | Common Stock | D | 2,427 | $58.32 | 171,786 | D | S |
| 10 Mar, 2026 | Jim Wassil | Common Stock | D | 4,968 | $59.16 | 166,818 | D | S |
| 10 Mar, 2026 | Jim Wassil | Common Stock | D | 4,968 | $59.16 | 166,818 | D | S |